Pfizer goes small for a big brand
Competition and a growing taste for herbal remedies is changing the way the pharma major is positioning one of its bestselling brands, Gelusil12-01-2016
12-01-2016
Pfizer hikes US prices for over 100 drugs on 1 January
Prices of some drugs raised by as much as a fifth; list price does not reflect discounts on offer09-01-2016
Pfizer hikes US prices for over 100 drugs on 1 January
Prices of some drugs raised by as much as a fifth; list price does not reflect discounts on offer09-01-2016
Authorised KMPs to determine materiality of events/information
Pfizer Ltd has informed BSE regarding Authorised Key Managerial Personnel to determine materiality of events/information.08-12-2015
Appointment of Director
Pfizer Ltd has informed BSE that the Board of Directors of the Company has appointed Ms. Lu Hong as an Additional Director (Non-executive Woman Director) of the Company, effective December 04, 2015. The appointment of Ms. Lu Hong will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.Ms. Lu Hong does not hold any shares in the Company.05-12-2015
Pfizer leaving US unsettles drug lobbyists
The lobbyists asked for anonymity since criticising Pfizer or the industry's present position in Washington could get them fired27-11-2015
Pfizer and Allergan to Combine
Pfizer Ltd has informed BSE regarding a Press Release titled "Pfizer and Allergan to Combine".24-11-2015
Pfizer to buy Allergan in $160 bn deal to create world's No 1 drugmaker
Pfizer to buy Allergan in $160 bn deal to create world's No 1 drugmaker New York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allergan share.23-11-2015
Aurobindo gets USFDA nod for generic of Pfizer's Revatio
The product, used to treat high blood pressure in lungs, is expected to be launched in the fourth quarter of the current fiscal21-11-2015
US unveils new inversion rules; unlikely to thwart Pfizer
The U.S. Treasury Department on Thursday took steps to clamp down on tax-avoiding "inversion" deals with new rules, though there was scarce evidence they would stop the biggest inversion...20-11-2015